




Searching News Database: Debiopharm
HSMN NewsFeed - 1 Jun 2017
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
HSMN NewsFeed - 5 Mar 2014
Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group(TM)
Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group(TM)
HSMN NewsFeed - 28 Nov 2012
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
HSMN NewsFeed - 18 Jun 2012
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
HSMN NewsFeed - 23 Jun 2009
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
HSMN NewsFeed - 4 Nov 2008
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 12 Feb 2008
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 24 Jul 2006
Debiopharm Applies for First European Marketing Authorisation for Sanvar(R) in France
Debiopharm Applies for First European Marketing Authorisation for Sanvar(R) in France
Additional items found! 33

Members Archive contains
33 additional stories matching:
Debiopharm
(Password required)
Debiopharm
(Password required)